Search

everythinglearnresearchcommunity

for

Search:↓

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

New compounds may help treat prostate cancer by reducing cell growth.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Finasteride may affect PNMT, causing side effects.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Finasteride and baicalin in phospholipid vesicles effectively promote hair growth and increase follicle count.

New compounds were made that are promising for prostate cancer therapy.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Finasteride's polymorphic form affects capsule quality and drug effect, requiring strict control.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The MPA-ISO cocrystal improved solubility and dissolution rate, while the others did not.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

Phospholipases help maintain and restore skin and hair health, potentially leading to new treatments for related conditions.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

New progesterone-based compounds can block male hormones.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

Using finasteride with TIP extends time off period for prostate cancer patients.